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Abstract 
Background: Campylobacter concisus is a Gram-negative bacterium that is associated with inflammatory bowel 
disease (IBD). Some C. concisus strains carry zonula occludens toxin (zot) gene which has polymorphisms. This study 
investigated the effects of C. concisus Zot on intestinal epithelial cells and macrophages using cell line models.
Methods: Campylobacter concisus zot808T gene, a polymorphism that is associated with active IBD, was cloned and 
expressed in Escherichia coli. The effects of C. concisus Zot on intestinal epithelial barrier were examined using Caco-2 
cell model. Apoptosis induced by C. concisus Zot in Caco-2 cells was assessed by measuring the levels of caspase 3/7. 
The production of pro-inflammatory cytokines induced by C. concisus Zot in HT-29 cells and in THP-1 macrophage-like 
cells was measured using ELISA kits. Whether exposure to C. concisus Zot can affect the responses of macrophages to 
E. coli K12 was also investigated.
Results: Campylobacter concisus Zot caused prolonged intestinal epithelial barrier damage, induced intestinal epithe-
lial cell apoptosis, induced epithelial production of TNF-α and IL-8 and upregulated TNF-α in THP-1 macrophage-like 
cells. Pre-exposure to C. concisus Zot significantly enhanced the production of TNF-α and IL-8 as well as phagocytosis 
by THP-1 macrophage-like cells in response to E. coli K12.
Conclusion: This study suggests that C. concisus Zot may have enteric pathogenic potential by damaging intestinal 
epithelial barrier, inducing intestinal epithelial and macrophage production of proinflammatory cytokines in particular 
TNF-α and enhancing the responses of macrophages to other enteric bacterial species.
Keywords: Zonula occludens toxin, Campylobacter concisus, Oral Campylobacter species, Inflammatory bowel disease
© 2016 Mahendran et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Campylobacter concisus is a Gram-negative bacterium 
that is associated with inflammatory bowel disease (IBD). 
A number of studies have detected a significantly higher 
prevalence of C. concisus in faecal samples and intestinal 
biopsies from patients with IBD as compared to controls 
[1–4]. The human oral cavity is the natural coloniza-
tion site of C. concisus [5, 6]. However, C. concisus may 
colonize the intestinal tract in some individuals. Stud-
ies have shown that there are no distinct oral or enteric 
C. concisus strains and that C. concisus colonizing the 
human intestinal tract has originated from the individu-
al’s own oral cavity or oral C. concisus strains from other 
sources [7, 8]. Previous studies suggested that some oral 
C. concisus strains have the potential to cause enteric dis-
ease [7, 9, 10]. In addition to patients with IBD, C. con-
cisus was also frequently isolated from stool samples of 
patients with diarrheal disease [11–14].
A number of studies have identified potential viru-
lence factors in C. concisus strains isolated from patients 
with IBD and in some instances healthy individuals 
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[13, 15–17]. A study by Istivan et  al. characterised and 
showed the effects of C. concisus phospholipase A on 
Chinese hamster ovary cells [15]. The other potential vir-
ulence factors in C. concisus and their abilities to cause 
any pathogenic changes to human cells remain to be 
investigated. One of such potential virulence factor is C. 
concisus zonula occludens toxin (zot) gene. Previously we 
detected the zot gene in 30 % of oral C. concisus strains 
and C. concisus zot808T polymorphism was found to be 
associated with active IBD [17].
The zot gene was first detected in Vibrio cholerae and 
is encoded by CTX prophage [18]. The N terminus of V. 
cholerae Zot is involved in CTXφ morphogenesis while 
the C terminus is cleaved and secreted into the intestinal 
lumen [19]. The C terminal-fragment of V. cholerae Zot 
activates an intracellular signalling pathway by binding to 
proteinase activated receptor-2, which increases intesti-
nal epithelial permeability by affecting the tight junctions 
[19].
Campylobacter concisus zot is carried by prophage 
CON_phi2 which is different from V. cholerae CTX 
prophage [20]. Campylobacter concisus Zot and V. chol-
erae Zot have only 16 % amino acid identity. To date, the 
biological effects of C. concisus Zot on human cells have 
not been investigated. In this study, the effects of C. con-
cisus Zot on intestinal epithelial integrity, the phagocytic 
capacity of macrophages and production of pro-inflam-
matory cytokines in intestinal epithelial cells and mac-
rophages were investigated using cell line models. The 
results from this study suggest that C. concisus Zot may 
have enteric virulent properties.
Methods
Expression of C. concisus zot 808T gene in Escherichia coli 
system
The full length C. concisus zot808T gene was amplified 
from the C. concisus strain P14UCO-S1 by polymerase 
chain reaction (PCR) [17]. The PCR primers used for 
amplification are listed in Table 1. The amplified zot gene 
was cloned into plasmid vector pETBlue-2 with 6-histi-
dines tagged at the C-terminus and expressed using a 
commercially available E. coli expression system follow-
ing the manufacturer’s instructions (Novagen, WI, USA). 
The E. coli strain used for recombinant protein expres-
sion was BL21 (DE3) pLacI.
Nickel bound (Ni–NTA) agarose beads were used 
for partial purification of the expressed C. concisus Zot 
(Gold biotechnology, Inc., MO, USA). Proteins eluted 
from the Ni–NTA columns contained both the Zot 
protein of P14UCO-S1 and E. coli proteins (EP). These 
proteins were termed as EP-ZotP14UCO-S1. In order 
to ensure that the effects observed were due to C. con-
cisus Zot proteins and not EP proteins, EP proteins were 
prepared by transforming E. coli BL21 (DE3) pLacI cells 
with pETBlue-2 vector; inducing the E. coli bacteria and 
purifying the proteins using identical protocols as for the 
purification of EP-ZotP14UCO-S1. The EP proteins were 
included in all experiments. All the experimental data 
from EP-ZotP14UCO-S1 were compared with that from 
the EP proteins.
The proteins eluted from Ni–NTA columns were fil-
tered through 0.22 μm filter and then concentrated and 
buffer-exchanged to DPBS using an Amicon® Ultra 10K 
column (Merck Millipore Ltd, Carrigtwohill, Ireland). 
The total protein concentrations were determined using a 
BCA assay kit (Thermo Fisher Scientific, MA, USA). The 
presence of C. concisus Zot in EP-ZotP14UCO-S1 was 
confirmed using anti-histidine antibody (Qiagen, Hilden, 
Germany) by Western blot as previously described [21].
Examination of the effects of C. concisus Zot on intestinal 
epithelial barrier
Colorectal adenocarcinoma Caco-2 cells develop a mon-
olayer of cells which express several morphological and 
functional characteristics that are similar to mature 
human enterocytes including assembly of the tight junc-
tions, which have been extensively used as a model of 
intestinal epithelial barrier [22–24]. Campylobacter con-
cisus was shown to damage intestinal epithelial barrier 
using Caco-2 cell model previously [25]. In this study, 
whether C. concisus Zot causes damage to intestinal bar-
rier was investigated using Caco-2 cell model by examin-
ing the effects of EP and EP-ZotP14UCO-S1 proteins on 
transepithelial electrical resistance (TEER) and paracellu-
lar marker passage [26, 27]. Caco-2 cells were cultivated 
and maintained as previously described [7].
Caco-2 cells were grown on transwells with the pore size 
0.4  μm for 21  days before utilization for TEER measure-
ment (Millipore). TEER was measured using an Epithelial 
Volt/Ohm Meter (World Precision Instruments, FL, USA).
Table 1 Sequences of primers used for zot gene cloning
Extra base pairs on the 5′ end of the primer are underlined and denote leader sequences, sequences in italics denote restriction enzyme sites for NcoI, sequences in 
italics and the symbol^ denote restriction enzyme site for XhoI, sequences in bold denote zot gene sequences
Primers Sequence (5′–3′) Reference
F_pETB2_P14UCO-S1 CACATG –CCATGG-CGATGTTAAGTTTGATTATAGGTCCG This study
R_pETB2_P14UCO-S1 CAATAA –CTCGAG^-CTTGAGAGTAGGAAGCATAGG
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For TEER measurement, Caco-2 cells were incubated 
with 12.5 and 50  μg EP and EP-ZotP14UCO-S1 pro-
teins dissolved in 100 μl DPBS respectively. Caco-2 cells 
incubated with DPBS were used as the negative control. 
Dimethyl sulfoxide (DMSO) (10  %), which is known 
to cause cell death, was used as the positive control for 
TEER measurement [28]. This positive control was to 
ensure that the damaged intestinal epithelial barrier is 
reflected by the decrease of TEER in our experimental 
conditions. The levels of TEER in Caco-2 cells treated 
with EP and EP-ZotP14UCOS1 proteins were expressed 
as a percentage relative to their time 0 TEER values 
respectively.
We aimed to examine both the short term effect and 
the prolonged effect of C. concisus Zot on TEER. For 
the short term effect, EP and EP-ZotP14UCO-S1 were 
incubated with Caco-2 cells for up to 4 h and TEER was 
measured at times 0, 2 and 4 h. The proteins and DPBS 
in the negative control cells were removed following 4 h 
of incubation in Caco-2 cells and the normal cell culture 
media was added. TEER was measured again at different 
time points after the removal of C. concisus Zot and this 
was regarded as the prolonged effect of C. concisus Zot 
on TEER.
Paracellular marker assay was carried out by using 
fluorescein-labelled dextran 4000 (FD4). Given that EP-
ZotP14UCO-S1 (50  μg protein dissolved in 100  μl of 
DPBS) caused a significant decrease of TEER in Caco-2 
cells after 2 h of incubation in the above experiment, the 
same time point was also used for the paracellular marker 
assay. Caco-2 cells were grown as mentioned above and 
were incubated with EP and EP-ZotP14UCO-S1 proteins. 
Caco-2 cells incubated with DPBS were used as the nega-
tive control and 10  % DMSO treated Caco-2 cells were 
used as the positive control [28]. Following 2 h of incuba-
tion, cells were washed with DPBS and 700 μg/ml of FD4 
was added. The cells were incubated for further 2 h and 
the passage of FD4 was then measured. The permeabil-
ity of FD4 was calculated as apparent permeability coef-
ficient (Papp) value as previously described [26].
Measurement of caspase 3/7 activity in Caco‑2 cells 
induced by C. concisus Zot
Caspase 3/7 activity was measured in order to examine 
whether C. concisus Zot caused apoptosis in Caco-2 cells. 
Caco-2 cells were cultured on black-walled 96-well plates 
with transparent bottom for 2  days and then incubated 
with EP and EP-ZotP14UCO-S1 proteins at 50 μg/100 μl 
for 2 h. Caco-2 cells incubated in DPBS were used as the 
negative control and DMSO (5  %) treated Caco-2 cells 
were used as the positive control [29]. Caspase 3/7 activ-
ity was then measured using fluorescent CellEvent Cas-
pase-3/7 Green ReadyProbes Reagent (Thermo Fisher 
Scientific) as per the manufacturer’s instruction [28]. The 
level of caspase 3/7 activity in Caco-2 cells treated with 
EP and EP-ZotP14UCO-S1 were expressed as folds rela-
tive to that in the negative control Caco-2 cells.
Measurement of pro‑inflammatory cytokines in HT‑29 cells 
induced by C. concisus Zot
Whether C. concisus Zot can induce intestinal epithe-
lial production of proinflammatory cytokines was inves-
tigated. We initially measured IL-8 and TNF-α in the 
supernatants of Caco-2 cells treated with EP and EP-
P14UCOS1 for 8 and 24 h. However, the cytokine levels 
produced by Caco-2 cells in our experiments were unde-
tectable. Given this, human colon carcinoma HT-29 cells, 
which are known to produce higher levels of pro-inflam-
matory cytokines, were used to examine the effects of EP 
and
EP-P14UCOS1 proteins on induction of intestinal epi-
thelial production of proinflammatory cytokines [30–32]. 
A previous study showed that C. concisus strains induced 
apoptosis in HT-29 cells [9]. However, in this study we 
did not examine the apoptosis in EP and EP-P14UCOS1 
treated HT-29 cells given that some proinflammatory 
cytokines are known to cause apoptosis.
HT-29 cells were cultivated and maintained as previ-
ously described [21]. HT-29 cells were treated with EP 
and EP-ZotP14UCO-S1 proteins (50 μg in 100 μl) for 24 h 
and supernatants were collected. The levels of TNF-α and 
IL-8 in the HT-29 culture media were quantitated using 
Human TNF-α and IL-8 CytoSet (Thermo Fisher Scien-
tific). HT-29 cells incubated in DPBS were used as the 
negative control and C. concisus strain P1CDO3 at MOI 
200 was used as the positive control [21]. The purpose of 
the positive control in this experiment was to ensure the 
cells used were able to elicit production of pro-inflamma-
tory cytokines in response to bacteria or their products. 
P1CDO3 was shown to induce IL-8 production in HT-29 
cells in our previous study, therefore was used as the pos-
itive control in this study [21].
Measurement of proinflammatory cytokines in THP‑1 
macrophages‑like cells induced by C. concisus Zot
THP-1 is a human monocytic cell line derived from an 
acute monocytic leukemia patient. Once treated with 
phorbol 12-myristate 13-acetate (PMA), THP-1 cells 
undergo greater differentiation to become macrophage-
like cells and have increased adherence and expression 
surface markers, which have been frequently used a cell 
culture model for macrophages [33]. Campylobacter 
concisus was previously shown to induce the production 
of proinflammatory cytokines in THP-1 macrophage-
like cells [25]. To examine whether C. concisus Zot have 
effects on macrophage functions, we examined the 
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production of IL-8 and TNF-α production in THP-1 
macrophage-like cells and the responses of THP-1 mac-
rophage-like cells to other bacterial species following the 
incubation with EP and EP-P14UCOS1.
THP-1 macrophage-like cells were maintained as pre-
viously described [34]. PMA (10  nM) (Sigma-Aldrich, 
NSW, Australia) was added to the cells for 2  days to 
allow the differentiation of THP-1 cells to macrophage-
like cells. The cells were then cultured in media without 
PMA for further 2  days prior to experiments. THP-1 
macrophage-like cells (1 × 105/well in 96-well plate) were 
incubated with EP and EP-ZotP14UCO-S1 proteins at 
50 μg/100 μl for 2 h.
The supernatants were collected and the levels of 
TNF-α and IL-8 were measured as described above. 
THP-1 macrophage-like cells incubated in DPBS were 
used as the negative control and the resulting levels of 
cytokines were subtracted from the test samples. Campy-
lobacter concisus strain P1CDO3 at MOI 200 was used as 
the positive control to ensure that THP-1 macrophage-
like cells elicited production of pro-inflammatory 
cytokines.
The effect of pre‑exposure to C. concisus Zot on the 
phagocytic capacity of THP‑1 cells to E. coli K12 
and cytokine production
We are interested in examining whether exposure to C. 
concisus Zot affects the responses of macrophages to 
other enteric bacterial species. To investigate this, we 
examined the phagocytosis of THP-1 macrophage-like 
cells to E. coli K12 and cytokine production. Vybrant 
Phagocytosis Assay kit (Molecular Probes, Oregon, USA) 
was used to measure phagocytosis in EP and EP-Zot-
P14UCO-S1 proteins treated macrophages.
THP-1 macrophages like cells were incubated with EP 
and EP-ZotP14UCO-S1 proteins at 50 μg/100 μl for 2 h 
as described above. The controls were included as per 
the manufacturer’s instruction. The negative control for 
this assay constituted of microplate wells containing only 
media incubated with E. coli K12 Bioparticles. The posi-
tive control for this assay constituted of untreated THP-1 
macrophages-like cells which were incubated with E. 
coli K12 Bioparticles. Post incubation, the proteins were 
removed and cells were washed.
Fluorescein-labelled E. coli K12 BioParticles (100  μl) 
were subsequently added to the cells. Following 2  h 
of incubation, supernatant was removed and used for 
measurement of TNF-α and IL-8 as described above. 
The phagocytosed E. coli K12 BioParticles were meas-
ured using a Fluorescence Plate Reader as per the man-
ufacturer’s instruction. The levels of phagocytosis in 
THP-1 macrophage-like cells treated with EP and EP-
ZotP14UCO-S1 proteins were expressed as percentage 
relative to that of the positive control after subtraction 
from the value of the negative control.
Statistical analysis
Data were analyzed by means of unpaired Student’s t test 
using GraphPad, Prism version 5.1 (San Diego, CA). P 
values less than 0.05 (two tailed, 95 % confidence inter-
val) indicated statistical significance.
Results
The effect of different concentrations of EP‑ZotP14UCO‑S1 
on TEER of Caco‑2 cells
Two different concentrations of EP and EP-ZotP14UCO-
S1 proteins were used to treat Caco-2 cells. When 
12.5 μg of total proteins were used, a minor decrease in 
TEER was observed in Caco-2 cells treated with EP-Zot-
P14UCO-S1 as compared to EP treated Caco-2 cells fol-
lowing 2 and 4 h of incubation (Fig. 1a). However, TEER 
increased after removal of the proteins. When 50 μg total 
proteins were used, EP-ZotP14UCO-S1 caused a signifi-
cant decrease of TEER as compared to EP treated cells 
following 2 and 4 h of incubation (Fig. 1b) (P < 0.001).
The TEER level measured at 24 h after the removal of 
the proteins in Caco-2 cells treated with EP-ZotP14UCO-
S1 was still significantly lower than that in Caco-2 cells 
treated with EP (P  <  0.05) (Fig.  1b). This showed that 
EP-ZotP14UCO-S1 had a prolonged effect on the TEER 
of Caco-2 cells. Given this, 50 μg of total proteins resus-
pended in 100  μl DPBS was used for the remaining 
experiments. DMSO treated cells caused TEER to drop 
to 59 ± 4.0 and 97 ± 2.8 % of its initial TEER after 2 and 
24 h of incubation respectively. The TEER in Caco-2 cells 
incubated in DPBS remained stable through the course of 
the experiment.
The effect of EP‑ZotP14UCO‑S1 on paracellular 
permeability in Caco‑2 cells
The effect of EP-ZotP14UCO-S1 on Caco-2 paracellu-
lar permeability was examined by using the paracellular 
marker FD4. The Papp value in Caco-2 cells treated with 
EP-ZotP14UCO-S1 was 1.97  ±  0.2 and this was signifi-
cantly higher as compared to EP treated cells (1.33 ± 0.1, 
P < 0.01) (Fig. 2). This indicated that the decrease in TEER 
induced by EP-ZotP14UCO-S1 at 2 h directly correlated 
with an increase in paracellular permeability. The Papp 
value caused by 10 % DMSO treated cells was 4.58 ± 0.1.
The effect of EP‑ZotP14UCO‑S1 on Caco‑2 cells apoptosis
Caspase 3/7 levels were measured to examine for apop-
tosis induced by C. concisus Zot in Caco-2 cells. The cas-
pase 3/7 activity was 2.53 ± 0.03 in Caco-2 cells treated 
with EP-ZotP14UCO-S1, and this was significantly 
higher than that in cells treated with EP (1.53  ±  0.1, 
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P  <  0.05). The caspase 3/7 levels in 5  % DMSO treated 
cells were 2.68 ± 0.4.
The production of TNF‑α and IL‑8 in HT‑29 cells induced 
by EP‑ZotP14UCO‑S1
The levels of TNF-α and IL-8 in EP-ZotP14UCO-S1 
treated HT-29 cells were 14.8 ± 2.5 and 6173 ± 216 pg/
ml respectively. These levels were significantly higher 
than those induced by EP treated cells (P < 0.05) (Fig. 3a, 
b). TNF-α and IL-8 levels in HT-29 cells incubated with 
C. concisus strain P1CDO3 were 34 ± 8 and 246 ± 27 pg/
ml respectively.
The production of TNF‑α and IL‑8 in THP‑1 
macrophage‑like cells induced by EP‑ZotP14UCO‑S1
In THP-1 macrophage-like cells, EP-ZotP14UCO-
S1 (2640  ±  42  pg/ml) induced a significantly higher 
production of TNF-α as compared to EP treated cells 
(1318 ± 25 pg/ml) (P < 0.05) (Fig. 3c). EP-ZotP14UCO-
S1 treated cells did not induce a significant change 
in the production of IL-8 as compared to EP treated 
cells (Fig.  3d). TNF-α and IL-8 production in THP-1 
cells incubated with C. concisus strain P1CDO3 were 
1738 ± 230 and 1708 ± 187 pg/ml respectively.
The effect of exposure to EP‑ZotP14UCO‑S1 on the 
responses of THP‑1 macrophage‑like cells to E. coli K12
The levels of TNF-α and IL-8 levels induced by E. coli 
K12 in THP-1 cells without pre-exposure to C. concisus 
Zot were subtracted from the data present in Fig.  4a, 
b. Pre-exposure to EP for 2  h did not appear to affect 
the production of TNF-α in THP-1 cells in response 
to E. coli K12 (Fig.  4a). THP-1 cells produced signifi-
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Fig. 1 The effect of C. concisus Zot on TEER. Caco-2 cells grown for 21 days were treated apically with two concentrations (a 12.5 μg/100 μl, b 
50 μg/100 μl) of EP and EP-ZotP14UCO-S1 proteins dissolved in DPBS. Caco-2 cells in DPBS were utilized as the negative control. Following 4 h 
of incubation, the proteins and DPBS were removed and cells were further incubated. TEER was measured at different time points. TEER was 
expressed as the percentage relative to TEER reading at time 0. Dotted lines indicate lapsed times between 8 and 24 h. The levels of TEER in Caco-2 
cells treated with EP-ZotP14UCO-S1 and EP were compared. The TEER values for DMSO treated cells were 59 ± 4.0 %. * Indicates P < 0.05 and *** 
Indicates P < 0.001. Data are shown as the mean ± SD from triplicates and are representative of three independent experiments. EP-ZotP14UCO-S1: 
constituted of E. coli proteins and the Zot of C. concisus strain P14UCO-S1 expressed in E. coli. EP control E. coli proteins. TEER transepithelial electrical 
resistance
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EP-ZotP14UCO-S1 (210 ± 28 pg/ml) when compared to 
EP treated cells (0.65 ± 0.01 pg/ml) (P < 0.01) (Fig. 4a). 
The levels of IL-8 produced by THP-1 cells in response 
to E. coli K12 following pre-exposure to EP-ZotP14UCO-
S1 (650 ± 25 pg/ml) were also significantly higher when 
compared to EP (273 ± 39 pg/ml) (P < 0.05) (Fig. 4b).
The effect of pre‑exposure to C. concisus Zot on the 
phagocytic capacity of THP‑1 cells to E. coli K12
The exposure to EP-ZotP14UCO-S1 (184  ±  4  %) for 
2  h significantly increased the phagocytosis of E. coli 
by THP-1 cells when compared to cells exposed to EP 
treated cells (100 ± 2) (P < 0.01) (Fig. 4c).
Discussion
In this study, we examined the effects of C. concisus Zot 
on intestinal epithelial cells and macrophages using cell 
line models.
EP-ZotP14UCO-S1 caused a significant decrease in 
TEER and an increase in paracellular permeability as 
compared to EP proteins in Caco-2 cell intestinal epi-
thelial barrier model. Interestingly, the TEER level in 
Caco-2 cells treated with EP-ZotP14UCO-S1 remained 
significantly lower 24  h after the removal of the pro-
teins (Figs. 1b, 2). The poor recovery of TEER levels after 
24  h in EP-ZotP14UCO-S1 treated Caco-2 cells sug-
gests that apoptosis had occurred in these cells. Indeed, 
EP-ZotP14UCO-S1 proteins caused a significant increase 
in caspase 3/7 levels in Caco-2 cells as compared to EP 
proteins, suggesting that apoptosis could be a possible 
mechanism contributing to the decreased TEER. Induc-
tion of epithelial apoptosis by EP-ZotP14UCO-S1 in 
Caco-2 cells suggests that C. concisus Zot may contrib-
ute to enteric disease through causing a prolonged dam-
age to intestinal epithelial barrier. We have measured the 
levels of IL-8 and TNF-α in the supernatants of Caco-2 
cells following incubation with EP and EP-ZotP14UCO-
S1 for 8 and 24 h. However, the levels of these cytokines 
produced by Caco-2 cells were undetectable. These data 
suggest that the apoptosis induced by EP-ZotP14UCO-S1 
in Caco-2 cells was due to a different mechanism rather 
than through the induction of TNF-α.
In addition to causing damage to the intestinal epithe-
lial barrier in Caco-2 cells, EP-ZotP14UCO-S1 induced 
significantly higher production of TNF-α and IL-8 in 
HT-29 cells and a significantly higher production of 
TNF-α in the macrophages (Fig.  3a, b). TNF-α plays a 
central role in the pathogenesis of IBD [35]. The levels of 
TNF-α are raised in the serum, mucosa and stool of IBD 
patients [36–38]. Treatment using monoclonal anti-TNF 
antibody has shown to be a successful therapy in a sub-
group of IBD [36–38]. Overproduction of TNF by intes-
tinal epithelial cells was shown to cause full advancement 
of Crohn-like pathology in an animal model [39]. The 
increased elicitation of TNF-α by EP-ZotP14UCO-S1 in 
intestinal epithelial cells and macrophages suggests that 
C. concisus Zot may be a key microbial factor in initiating 
and contributing to the pathogenesis of IBD. However, 
this speculation requires further investigation.
Exposure to EP-ZotP14UCO-S1 significantly enhanced 
the responses of THP-1 macrophage-like cells to E. coli 
K12. This included increased production of pro-inflam-
matory cytokines and phagocytic activities (Fig.  4a–c). 
The molecular mechanism for this is not clear. One prob-
able cause of this effect could be that TNF-α produced 
by macrophages during pre-incubation with EP-Zot-
P14UCO-S1 had activated the THP-1 macrophage-like 
cells [40]. The finding that exposure to EP-ZotP14UCO-S1 
enhanced the responses of THP-1 macrophage-like cells 
to E. coli K12 suggests that C. concisus Zot has the poten-
tial to influence the responses of intestinal innate immune 
system to enteric resident bacterial species, which may 
contribute to chronic mucosal inflammation. Future stud-
ies should be conducted for further investigation.
Despite the interesting findings, this study is not with-
out its own limitations. The expression level of C. con-
cisus Zot in E. coli was low and thus partially purified Zot 
was used (Additional file 1: Figure 1A, B). Various experi-
mental conditions were employed to increase the expres-



















Fig. 2 The effect of C. concisus Zot on the passage of paracellular 
marker. Caco-2 cells grown for 21 days were treated with 50 μg/100 μl 
of EP and EP-ZotP14UCO-S1 proteins for 2 h. Cells were then washed 
with DPBS and 700 μg/ml of fluorescein-labelled dextran 4000 (FD4) 
was added. The cells were further cultured for 2 h and the passage of 
FD4 was measured. The permeability of FD4 was calculated as appar-
ent permeability coefficient (Papp). The Papp value caused by 10 % 
DMSO treated cells was 4.58 ± 0.1. Data are shown as the mean ± SD 
from triplicates and are representative of three independent experi-
ments. ** Indicates P < 0.01. EP-ZotP14UCO-S1: constituted of E. coli 
proteins and the Zot of C. concisus strain P14UCO-S1 expressed in E. 
coli. EP control E. coli proteins
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of C. concisus Zot eluted from Ni–NTA columns, which 
yielded limited success. We noted that the growth of E. 
coli that were transformed with pETBlue-2-zot808Tceased 
following the induction of Zot expression and the E. coli 
bacteria appeared to be less healthy under microscope, 
as compared to E. coli bacteria that were transformed 
with pETBlue-2 vector alone. This suggests that C. con-
cisus Zot may be toxic to host E. coli bacteria, which is 
a possible factor contributing to the low level expression 
of C. concisus Zot in E. coli. Changing imidazole and salt 
concentrations and inclusion of some detergents in the 
purification of C. concisus Zot did not further increase 
the purity of Zot protein eluted from Ni–NTA columns. 
Nevertheless, in this study we included the same con-
centrations of EP proteins in all experiments. EP-Zot-
P14UCO-S1 and EP proteins clearly had different effects 
on intestinal epithelial cells and macrophages. These 
results provide initial evidence that C. concisus Zot has 
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Fig. 3 The effect of C. concisus Zot on the production of TNF-α and IL-8 in HT-29 and THP-1 macrophage-like cells. HT-29 cells (a and b) HT-29 cells 
were treated with EP and EP-ZotP14UCO-S1 proteins at 50 μg/100 μl for 24 h. The supernatants were collected and the levels of TNF-α and IL-8 
were measured using commercially available ELISA kits. TNF-α and IL-8 levels in P1CDO3 treated cells were 34 ± 8 and 246 ± 27 pg/ml respectively. 
THP-1 macrophage-like cells (c and d) THP-1 macrophage-like cells were treated with EP and EP-ZotP14UCO-S1 proteins at 50 μg/100 μl for 2 h. 
The supernatants were collected and the levels of TNF-α and IL-8 were measured using commercially available ELISA kits. Data are shown as the 
mean ± SD from triplicates and are representative of two independent experiments. The value in the negative control (cells without any treatment) 
was subtracted from the data presented in this figure. TNF-α and IL-8 levels in P1CDO3 treated cells were 1738 ± 230 and 1708 ± 187 pg/ml respec-
tively. *P < 0.05, **P < 0.01 and ***P < 0.001. EP-ZotP14UCO-S1: constituted of E. coli proteins and the Zot of C. concisus strain P14UCO-S1 expressed 
in E. coli. EP control E. coli proteins
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Conclusion
In summary, using cell culture models we found that 
C. concisus Zot caused prolonged intestinal epithelial 
barrier damage, induced intestinal epithelial apoptosis 
and intestinal epithelial production of TNF-α and IL-8. 
Furthermore, C. concisus Zot upregulated the production 
of TNF-α in THP-1 macrophage-like cells and enhanced 
the responses of THP-1 macrophage-like cells to E. coli 
K12. These findings suggest that C. concisus Zot has the 
potential to cause enteric disease by damaging intestinal 
barrier, inducing intestinal epithelial and macrophage 
production of proinflammatory cytokines in particular 
TNF-α and enhancing the responses of macrophages to 
other enteric bacterial species.
Additional file
Additional file 1. SDS-PAGE and Western blot images of EP and EP-
ZotP14UCO-S1 proteins. EP and EP-ZotP14UCO-S1 proteins were purified 
from E. coli transformed with pETBlue-2 vector or pETBlue-2-zot808T using 
Ni–NTA columns as per manufacturer’s instruction. The flow through, 
column wash and eluates were collected and subjected to SDS-PAGE to 
reveal proteins. Eluates were also subjected to Western blot to detect Zot 
using anti-histidine antibodies. A and B purification of EP, A showing SDS-
PAGE and B showing Western blot. C and D purification of EP-ZotP14UCO-
S1, C showing SDS-PAGE and D showing Western blot. The Zot protein (44 
kD) was detected in EP-P14UCO-S1 not in EP. FT (Flow through), W1 (first 
wash), W2 (second wash), El-E4 (elutions 1-4). E1 was used for conducting 






















































































































































































Fig. 4 Exposure to C. concisus Zot enhances the response of THP-1 macrophage-like cells to E. coli K12. The production of pro-inflammatory 
cytokines and phagocytosis by THP-1 macrophage-like cells enhances the response to E. coli K12 following exposure to C. concisus Zot were 
assessed. THP-1 cells were treated with EP and EP-ZotP14UCO-S1 at 50 μg/100 μl for 2 h. The proteins were removed and cells were washed with 
DPBS. Measurement of cytokines levels (a and b) the cells were then incubated with E.coli K12 Bioparticles for an additional 2 h and the super-
natants were used to measure TNF-α and IL-8 using commercially available ELISA kits. Phagocytosis (c) the phagocytosed E. coli K12 Bioparticles 
were measured using a Fluorescence Plate Reader. The values in the negative control were subtracted from the positive control and experimental 
wells. The levels of phagocytosis in THP-1 macrophage-like cells treated with different proteins were expressed as percentage relative to that of the 
positive control. Data are shown as the mean ± SD from triplicates and are representative of two independent experiments. ** Indicates P < 0.01. 
EP-ZotP14UCO-S1 constituted of E. coli proteins and the Zot of C. concisus strain P14UCO-S1 expressed in E. coli. EP control E. coli proteins
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